Filing Details

Accession Number:
0000711377-15-000030
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-26 17:21:07
Reporting Period:
2015-08-24
Filing Date:
2015-08-26
Accepted Time:
2015-08-26 17:21:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189021 Edward Bradley Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-24 5,100 $18.68 187,630 No 4 M Direct
Common Stock Disposition 2015-08-24 5,100 $51.00 182,530 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2015-08-24 5,100 $0.00 5,100 $18.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
108,737 2015-08-24 No 4 M Direct
Footnotes
  1. Options were granted on 8/24/2010, and became fully vested on 8/24/2015